Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons

[1]  B. Truman,et al.  Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. , 1987, The New England journal of medicine.

[2]  J. Goedert,et al.  Therapy may explain recent deficits in AIDS incidence. , 1990, Journal of acquired immune deficiency syndromes.

[3]  J. Eisenberg.  Sociologic influences on decision-making by clinicians. , 1979, Annals of internal medicine.

[4]  M A Fischl,et al.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.

[5]  D. Crane.  Physicians' attitudes toward the treatment of critically ill patients. , 1973, Bioscience.

[6]  M A Fischl,et al.  The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.

[7]  A. Epstein,et al.  Effects of patients' socioeconomic status and physicians' training and practice on patient-doctor communication. , 1985, The American journal of medicine.

[8]  A I Mushlin,et al.  Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical care. , 1977, Archives of internal medicine.

[9]  P. Sullivan,et al.  Seroprevalence of viral markers and toxoplasmosis in hiv positive persons comparing transmission risk groups , 1990 .

[10]  F. Cowan,et al.  Use of zidovudine for drug misusers infected with human immunodeficiency virus. , 1989, The Journal of infection.

[11]  W. Guerra.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter , 1991 .

[12]  J. E. Groves.  Taking care of the hateful patient. , 1978, The New England journal of medicine.

[13]  A. Epstein,et al.  Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. , 1989, JAMA.

[14]  E. Drucker.  Hidden values and health care. , 1974, Medical care.

[15]  J. Godbold,et al.  Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factors. , 1989, The American journal of medicine.

[16]  R. Andersen,et al.  The national profile of access to medical care: where do we stand? , 1984, American journal of public health.

[17]  H. Mitsuya,et al.  Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides. , 1989, The New England journal of medicine.

[18]  David Bardey,et al.  Small-Area Variation in Health Care Affecting the Choice of Cesarean Delivery: The Case of a Colombian Health Insurer , 2009 .